Bavarian Nordic A/S BVNRY:OTCPK

*Data is delayed | Exchange | USD
Last | 05/01/24 EDT
7.21UNCH (UNCH)
Volume
59
52 week range
5.95 - 10.65
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close7.21
  • 52 Week High10.65
  • 52 Week High Date06/13/23
  • 52 Week Low5.95
  • 52 Week Low Date10/30/23

Key Stats

  • Market Cap1.689B
  • Shares Out234.30M
  • 10 Day Average Volume1,329.88
  • Dividend-
  • Dividend Yield-
  • Beta1.56
  • YTD % Change-17.55

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close7.21
  • 52 Week High10.65
  • 52 Week High Date06/13/23
  • 52 Week Low5.95
  • 52 Week Low Date10/30/23
  • Market Cap1.689B
  • Shares Out234.30M
  • 10 Day Average Volume1,329.88
  • Dividend-
  • Dividend Yield-
  • Beta1.56
  • YTD % Change-17.55

RATIOS/PROFITABILITY

  • EPS (TTM)0.96
  • P/E (TTM)7.51
  • Fwd P/E (NTM)-
  • EBITDA (TTM)384.576M
  • ROE (TTM)16.87%
  • Revenue (TTM)1.014B
  • Gross Margin (TTM)65.18%
  • Net Margin (TTM)20.89%
  • Debt To Equity (MRQ)1.41%

EVENTS

  • Earnings Date-
  • Ex Div Date03/27/2020
  • Div Amount0.5935
  • Split Date-
  • Split Factor-

Latest On Bavarian Nordic A/S

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Bavarian Nordic A/S is a Denmark-based biotechnology company engaged in manufacturing of pharmaceutical preparations. The Company is involved in research and development innovations, production and commercialization of life-saving vaccines. Bavarian Nordic A/S offers travel health products including cholera, rabies, tick-borne encephalitis and typhoid vaccines, as well as vaccines sold and distributed in selected markets on behalf of third parties. The Company deals with...
Anders Pedersen M.D., Ph.D.
Deputy Chairman of the Board
Luc Debruyne
Independent Chairman of the Board
Paul Chaplin Ph.D.
President, Chief Executive Officer
Russell Thirsk
Executive Vice President, Chief Operating Officer
Henrik Juuel
Executive Vice President, Chief Financial Officer
Jean-Christophe May Pharm.D.
Executive Vice President, Chief Commercial Officer
Address
Philip Heymans Alle 3
Hellerup
2900
Denmark